Summary: A study found that elevated blood levels of LDL cholesterol, Lp(a), and CRP significantly increase long-term cardiovascular risk, suggesting blood tests could guide preventive treatments for heart disease.

Takeaways:

  1. Women with the highest LDL cholesterol levels had a 36% higher risk of heart disease, while elevated Lp(a) and CRP levels increased risks by 33% and 70%, respectively.
  2. Combining these markers revealed women with the highest levels faced a threefold increased risk for coronary heart disease.
  3. Early measurement of these biomarkers could help guide preventive therapies, with ongoing research exploring personalized treatments.

A research team set out to study whether blood measures of cholesterol and inflammation could predict cardiovascular disease decades later. If so, blood tests could help guide preventive treatments. 

Women’s Health Study

The team collected blood samples and medical information from nearly 28,000 health care providers nationwide who participated in the Women’s Health Study. Women who started the study between 1992-1995 at an average age of 55 were followed for up to 30 years.

The researcher team, led by Paul M. Ridker, MD, MPH, at Brigham and Women’s Hospital, assessed high-sensitivity C-reactive protein (CRP), a marker of inflammation, along with low-density lipoprotein (LDL) cholesterol and lipoprotein(a), or Lp(a), a lipid partly made of LDL. Results appeared on Aug. 31, 2024, in the New England Journal of Medicine.

During the study, 3,662 participants experienced a heart attack, stroke, surgery to restore circulation, or a cardiovascular-related death. Participants were grouped into five categories, ranging from those with the highest to lowest levels of each of the three markers.

Study Results

The team found that women with the highest levels of LDL cholesterol had a 36% greater risk for heart disease compared to those with the lowest levels. Those with the highest levels of Lp(a) had a 33% greater risk. Those with the highest levels of CRP had a 70% greater risk.

When all three measures were assessed together, women with the highest levels had more than 1.5 times the risk for stroke and more than triple the risk for coronary heart disease compared to women with the lowest levels. Although only women were assessed in this study, similar results would be expected in men.

“We can’t treat what we don’t measure, and we hope these findings move the field closer to identifying even earlier ways to detect and prevent heart disease,” Ridker says.

LDL cholesterol is routinely measured by healthcare providers. High levels can be treated with widely available therapies, such as statins. Lp(a) and CRP screening recommendations can vary. Therapies are available for those with elevated levels, and researchers are testing new approaches to personalize and improve treatment options.

Further reading: Pregnant Women Undertested for STIs